A novel circular RNA, hsa_circ_0046701, promotes carcinogenesis by increasing the expression of miR-142-3p target ITGB8 in glioma

被引:92
作者
Li, Guobin [1 ]
Yang, Haiying [1 ]
Han, Kun [1 ]
Zhu, Dezhang [2 ]
Lun, Peng [1 ]
Zhao, Yan [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Neurosurg, 16 Jiangsu Rd, Qingdao 266003, Shandong, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Dept Anesthesiol, Qingdao, Peoples R China
关键词
Glioma; hsa_circ_0046701; miR-142-3p; ITGB8; Proliferation; Invasion; CELL-PROLIFERATION; CANCER; INVASION;
D O I
10.1016/j.bbrc.2018.01.076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, we identified a novel circular RNA (circRNA), hsa_circ_0046701, in glioma cells. We measured the expression of hsa_circ_0046701 using qRT-PCR in glioma tissues and cell lines, and explored its functions using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, colony formation, and Transwell assays. Luciferase reporter assays were performed to validate the correlation between microRNA miR-142-3p and hsa_circ_0046701 or integrin subunit beta 8 (ITGB8). The results showed that hsa_circ_0046701 was significantly upregulated in glioma tissues and cell lines, and knockdown of hsa_circ_0046701 inhibited cell proliferation and invasion. Luciferase reporter assays indicated that hsa_circ_0046701 functions as a sponge for miR-142-3p and regulates the expression of ITGB8. Subsequently, functional assays revealed that silencing of hsa_circ_0046701 could upregulate miR-142-3p, resulting in downregulation of ITGB8. The results demonstrated that the hsa_circ_0046701 miR-142-3p/ITGB8 axis might play critical regulatory roles in the pathogenesis and development of glioma. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 36 条
[1]   MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review [J].
Ahir, Bhavesh K. ;
Ozer, Howard ;
Engelhard, Herbert H. ;
Lakka, Sajani S. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 120 :22-33
[2]   The biology and mathematical modelling of glioma invasion: a review [J].
Alfonso, J. C. L. ;
Talkenberger, K. ;
Seifert, M. ;
Klink, B. ;
Hawkins-Daarud, A. ;
Swanson, K. R. ;
Hatzikirou, H. ;
Deutsch, A. .
JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2017, 14 (136)
[3]   Non-coding RNA networks in cancer [J].
Anastasiadou, Eleni ;
Jacob, Leni S. ;
Slack, Frank J. .
NATURE REVIEWS CANCER, 2018, 18 (01) :5-18
[4]  
[Anonymous], GENES
[5]  
[Anonymous], CANC LETT
[6]   Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab [J].
Blumenthal, Deborah T. ;
Kanner, Andrew A. ;
Aizenstein, Orna ;
Cagnano, Emanuela ;
Greenberg, Ariel ;
Hershkovitz, Dov ;
Ram, Zvi ;
Bokstein, Felix .
WORLD NEUROSURGERY, 2018, 110 :E727-E737
[7]   Cutaneous Metastases of the Glioma [J].
Chang, Hao ;
Ding, Yasuo ;
Wang, Peng ;
Wang, Qing ;
Lin, Yuchang ;
Li, Bing .
JOURNAL OF CRANIOFACIAL SURGERY, 2018, 29 (01) :E94-E96
[8]   MicroRNA-216b inhibits cell proliferation and invasion in glioma by directly targeting metadherin [J].
Chen, Zhihua ;
Wu, Yaxiang ;
Song, Shuxin ;
Zhu, Xingen ;
Zhu, Jianming .
MOLECULAR MEDICINE REPORTS, 2017, 16 (06) :9749-9757
[9]   MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS [J].
Fan, Qian ;
Hu, Xiuting ;
Zhang, Haiyang ;
Wang, Shengguang ;
Zhang, Huilai ;
You, Chaoying ;
Zhang, Chen-Yu ;
Liang, Hongwei ;
Chen, Xi ;
Ba, Yi .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (04) :1311-1324
[10]  
Feng ZY, 2017, EUR REV MED PHARMACO, V21, P4844